Skye is planning to initiate a Phase 2b clinical trial in obesity for nimacimab with ENHANZE in the middle of 2026. This study will also assess the combination of nimacimab and a GLP-1R agonist.

Introduction: Subcutaneous emphysema (SE) is a clinical condition that occurs when air gets into soft tissues under the skin. This can occur in any part of the body depending on the type of pathology.

Objectives To investigate the efficacy and safety of subcutaneously (SC) administered tranexamic acid. Methods A retrospective chart review of the use of SC tranexamic acid in a single palliative care ...